A new AI model has become so good at predicting how molecules evolve over time that, in the future, it could speed up the costly and time-consuming process of testing new drugs. In the long term, this ...

Researchers at IMDEA Materials Institute have developed an artificial intelligence (AI)-based strategy to predict and assess ...

Ammonia rarely makes headlines, but much of modern life depends on it. The compound of nitrogen and hydrogen is the key ingredient in the fertilizers that help feed roughly half of the world's ...

Energy storage usually brings to mind batteries, capacitors, tanks of hydrogen, or maybe some giant gravity system hauling ...

For decades, scientists trying to build better catalysts have relied on a single guiding principle: there is one sweet spot, ...

An anticancer medication called TLD1433, a ruthenium(II) complex that has entered Phase II trials for conditions such as non-muscle-invasive bladder cancer, is now being repurposed to address one of ...

Ganymede’s auroras have always stood apart for one simple reason: this is a moon, not a planet, and yet it carries its own ...

Casgevy sickle cell gene therapy is now FDA-approved for children as young as two, opening access for 5,500 more U.S. kids.

Sofinnova Partners, a leading European life sciences venture capital firm, today announced that its portfolio company Myricx Bio ("Myricx") has reached agreement to be acquired by Novartis, for up to ...

New research and theories suggest the brain may remain active near death, shaping visions, memories, and possibly our sense ...

Published in the open-access journal Ferroptosis and Oxidative Stress, the review by Giovanni Cravin and Giorgio Cozza from ...